Pearl Pathways announces the hiring of Nancy Kant as Clinical Services Advisor to support biopharmaceutical and diagnostic life science companies.

Nancy Kant Pearl IRB experienced biopharmaceutical

Nancy Kant, MS

A skilled biologist, Kant brings over 35 years of experience in the pharmaceutical and diagnostics industries and academic basic research. Her expertise includes evaluating and implementing new technologies, developing novel clinical and research laboratory methods and bioassays, biochemical reagent manufacture testing, and coordinating external partnerships.

As Clinical Services Advisor, Kant coordinates and manages clinical research activities for Pearl Pathways’ clients, ensuring studies are conducted in accordance with the protocol, relevant SOPs, and good clinical practices.Kant also provides medical writing, CRO, and CRC support services in addition to coordinating IRB submission activities at the site or study level.

Diana Caldwell, President and CEO shares, “Our clients will benefit from Nancy’s extensive leadership experience navigating a variety of clinical research challenges in large multi-nationals and academia. She brings to our team expert technical knowledge of pharmaceutical, diagnostic, and biochemical product research. Nancy’s scientific background coupled with her strong project management skills make her a valuable resource for the biopharmaceutical, diagnostic, and medical device companies we serve. We are thrilled to have Nancy join our team.”

To learn more, view the full press release or Nancy Kant’s bio.